@article{971920ee231945f5b72fc6b177ca5538,
title = "Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry",
keywords = "Adult, Aged, Antirheumatic Agents, Arthritis, Psoriatic, Arthritis, Rheumatoid, Denmark, Female, Humans, Incidence, Male, Middle Aged, Multiple Sclerosis, Registries, Risk Factors, Spondylitis, Ankylosing, Tumor Necrosis Factor-alpha, Letter, Research Support, Non-U.S. Gov't",
author = "L Dreyer and M Magyari and B. Laursen and R Cordtz and F Sellebjerg and H. Locht",
year = "2016",
month = apr,
doi = "10.1136/annrheumdis-2015-208490",
language = "English",
volume = "75",
pages = "785--6",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "4",
}